Target intelligence / Profile preview

Human respiratory epithelial cell

Molecular classification
Other (cell type)
01

Overview

Human respiratory epithelial cells line the respiratory tract from the nasal cavity to the alveoli, forming a barrier that protects against inhaled pathogens, toxins, and particles. The epithelium is made up of several specialized cell types, such as ciliated cells, goblet cells, basal cells, club cells, and type I/II alveolar cells, each contributing to functions like mucociliary clearance, secretion of antimicrobial peptides, immune signaling, repair after injury, and gas exchange[1][5][7][8]. These cells orchestrate both innate and adaptive immune responses by interacting with immune cells and sensing pathogens through surface receptors, and their dysfunction is implicated in various respiratory diseases including infections, chronic inflammation, and cancer[2][4][8]. They are not considered a canonical therapeutic target as a molecule or receptor, but are critically involved in the pathophysiology and regenerative processes of the respiratory system.

Other names
Airway epithelial cellRespiratory tract epithelial cellTracheobronchial epithelial cellPulmonary epithelial cell
02

Biological functions

Barrier function (physical protection from pathogens, particles, and chemicals)Mucociliary clearance (removal of pathogens and particulates via mucus and cilia action)Innate immune response (recognition and signaling via pattern-recognition receptors such as TLRs, secretion of cytokines, chemokines, and antimicrobial peptides)Cell regeneration and repair (progenitor cell function, regeneration after injury)Gas exchange (in alveolar epithelium: type I and II cells)Glucose homeostasis (regulation of airway glucose concentration, with implications for infection susceptibility)
03

Disease associations

Infection (site of entry and defense against respiratory pathogens, affected in viral/bacterial/fungal diseases)Inflammation (regulation of inflammatory responses, contribution to asthma, COPD, allergic airway diseases)Cancer (epithelial cell transformation can lead to lung carcinoma)Other (involvement in fibrosis, cystic fibrosis, and diverse pulmonary pathologies)
04

Safety considerations

Impaired barrier function (associated with increased infection susceptibility and inflammation)Epithelial shedding or injury (can lead to loss of barrier, chronic disease)Overactive immune responses (may contribute to allergy/asthma)
05

Biomarkers

Secreted mucins (e.g., MUC5AC)β-defensins (e.g., HBD-2)Surfactant proteins (in alveolar cells)

Beyond the preview

Go deeper on Human respiratory epithelial cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human respiratory epithelial cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call